About Gynoveda
Gynoveda is a company based in Mumbai (India) founded in 2019 by Aarati Patil, Vishal Gupta, and Rachana Gupta.. Gynoveda has raised $10.95 million across 3 funding rounds from investors including Ex Libris Group, Wipro and India Alternatives. The company has 95 employees as of October 09, 2025. Gynoveda offers products and services including Fertility Tablets, PCOS Tablets, Delayed Periods Tablets, Early Periods Tablets, and White Discharge Tablets. Gynoveda operates in a competitive market with competitors including Sanfe, MildCares, Auntfloh, Aurelle Health and VWash, among others.
- Headquarter Mumbai, India
- Employees 95 as on 09 Oct, 2025
- Founders Aarati Patil, Vishal Gupta, Rachana Gupta
- Stage Minicorn
-
Sectors
HealthcareConsumer
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Gynoveda Femtech Private Limited
- Date of Incorporation 05 Jul, 2019
- Jurisdiction Mumbai, Maharashtra, India
-
Annual Revenue
$7.85 M (USD)17.09as on Mar 31, 2024
-
Net Profit
$-365.09 K (USD)71.32as on Mar 31, 2024
-
EBITDA
$-756.26 K (USD)41.7as on Mar 31, 2024
-
Total Equity Funding
$10.95 M (USD)
in 3 rounds
-
Latest Funding Round
$10 M (USD), Series A
Mar 03, 2023
-
Investors
Ex Libris Group
& 9 more
-
Employee Count
95
as on Oct 09, 2025
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Gynoveda
Gynoveda offers a comprehensive portfolio of products and services, including Fertility Tablets, PCOS Tablets, Delayed Periods Tablets, Early Periods Tablets, and White Discharge Tablets. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Boost fertility and improve egg quality naturally
Reverse PCOS and regulate monthly cycles effectively
Improve menstrual flow and ensure timely cycles
Regulate cycles and control heavy menstrual flow
Treat itching and discharge for intimate health
Manage weight and hot flashes during menopause
Reduce damage from smoking and environmental pollution
Restore blood lost during menstrual cycles
Prevent knee pain and support bone health
Unlock access to complete
Funding Insights of Gynoveda
Gynoveda has successfully raised a total of $10.95M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $10 million completed in March 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series A — $10.0M
-
First Round
First Round
(23 Oct 2019)
- Investors Count 10
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2023 | Amount | Series A - Gynoveda | Valuation | India Alternatives | |
| Jun, 2020 | Amount | Seed - Gynoveda | Valuation | Fireside Ventures |
|
| Oct, 2019 | Amount | Seed - Gynoveda | Valuation | Fireside Ventures |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Gynoveda
Gynoveda has secured backing from 10 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include Ex Libris Group, Wipro and India Alternatives. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity investment firm
|
Founded Year | Domain | Location | |
|
Venture debt funding and structured finance for innovative startups in India.
|
Founded Year | Domain | Location | |
|
RPG Ventures is focused on incubating and investing in new businesses.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Gynoveda
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Gynoveda
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Gynoveda Comparisons
Competitors of Gynoveda
Gynoveda operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sanfe, MildCares, Auntfloh, Aurelle Health and VWash, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Personal hygiene and body care products for women are provided.
|
|
| domain | founded_year | HQ Location |
An online internet-first brand offering menstrual hygiene products
|
|
| domain | founded_year | HQ Location |
Developer PMS relief supplements
|
|
| domain | founded_year | HQ Location |
Provides clinically proven supplements for women's health and PCOS care.
|
|
| domain | founded_year | HQ Location |
Internet first brand of female intimate hygiene pharmaceuticals product
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Gynoveda
Frequently Asked Questions about Gynoveda
When was Gynoveda founded?
Gynoveda was founded in 2019.
Where is Gynoveda located?
Gynoveda is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
Is Gynoveda a funded company?
Gynoveda is a funded company, having raised a total of $10.95M across 3 funding rounds to date. The company's 1st funding round was a Seed of $282.57K, raised on Oct 23, 2019.
How many employees does Gynoveda have?
As of Oct 09, 2025, the latest employee count at Gynoveda is 95.
What is the annual revenue of Gynoveda?
Annual revenue of Gynoveda is $7.85M as on Mar 31, 2024.
What does Gynoveda do?
Founded in 2019 and based in Mumbai, India, dietary supplements and Ayurvedic solutions are provided by the company for womens health concerns. Menstrual issues such as PCOS, infertility, irregular and painful periods, and menopause are addressed through Ayurveda integrated with technology and educational content. Operations focus on the healthcare sector, targeting related disorders in the Indian market.
Who are the top competitors of Gynoveda?
What products or services does Gynoveda offer?
Gynoveda offers Fertility Tablets, PCOS Tablets, Delayed Periods Tablets, Early Periods Tablets, and 5 more products and services.
Who are Gynoveda's investors?
Gynoveda has 10 investors. Key investors include Ex Libris Group, Wipro, India Alternatives, Alteria Capital, and Wipro Enterprises.
What is Gynoveda's valuation?
The valuation of Gynoveda is $31.1M as of Mar 2023.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.